26 Mar 2024 15:30
GSK plc (the 'Company')
Transaction notification
?
1. | Details of PDMR/person closely associated with them ('PCA') | |||||
a) | Name | Sally Jackson | ||||
b) | Position/status | SVP, Global Communications & CEO Office | ||||
c) | Initial notification/ amendment | Initial notification | ||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | GSK plc | ||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||
a) | Description of the financial instrument | Ordinary shares of 31 ¼ pence each ('Ordinary Shares') ISIN: GB0009252882
| ||||
b) | Nature of the transaction | The sale of 3,551 Ordinary Shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | N/A (single transaction)
| ||||
e) | Date of the transaction | 2024-03-25 | ||||
f) | Place of the transaction
| London Stock Exchange (XLON) | ||||
Glaxosmithkline (GSK)